Inhaled Steroid For Early COVID-19: Increased Clinical Recovery And Decreased Persistent Symptoms?

Whiteboard Doctor | May 2, 2021

Inhaled Budesonide, a steroid medication, for the treatment of early COVID-19. This new research study published in Lancet found that in early COVID-19 inhaled Budesonide may increase the probability of clinical recovery, decrease the risk for decompensation, and prevent persistence of symptoms (decrease the potential for Long Haulers?)

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!